RANCHO CUCAMONGA, CA / ACCESS Newswire / May 27, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, ...

The Best Botox certification for nurses is through AACM SEATTLE, WA / ACCESS Newswire / May 27, 2026 / As the cosmetic injectables market continues to expand across the United States, registered ...

BLEEDnFIRE pioneers first RNA therapy targeting protein S, key regulator of coagulation cascade, offering new therapeutic strategy for patients across multiple rare bleeding disordersSupport from ...

UPPSALA, SE / ACCESS Newswire / May 27, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that its TetraGraph® neuromuscular monitoring system has received an additional FDA Class II ...

Share capital increase without shareholders’ preferential subscription rights, to be carried out by way of an issue of ordinary shares in the framework of a public offering, for an amount of ...

Award funds collaboration with leading Parkinson’s researcher, Dr. Tim Greenamyre, to investigate a novel therapeutic approach for Parkinson’s disease      SAN CARLOS, Calif.--(BUSINESS WIRE)--Acurex ...

ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that it will release financial results for the fourth quarter and full year 2025 results after the market ...

New data support potential use of plozasiran without dose adjustment in patients with moderate-to-severe renal or moderate hepatic impairment- Case report suggests that preconception exposure to ...

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, ...

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, ...

Aphios Corporation today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of ...

Collaborations with Gordion Bioscience and Tangramed Biotech, two AI-specialized companies, further strengthen Biomunex's integration of artificial intelligence (AI) into its R&D activities and ...